Imidazolylpyrrolone-Based Small Molecules as Anticancer Agents for Renal Cell Carcinoma.

"Conflict of interest The authors declare no conflict of interest."

"We acknowledge the financial support from University of Minho, Fundação para a Ciência e a Tecnologia (FCT) and FEDER‐COMPETE for financial support through (UID/QUI/00686/2013, UID/QUI/0686/2016, UIDB/50026/2020 and UIDP/50026/2020), for the PhD grant awarded to Olívia Pontes (SFRH/BD/128850/2017) and to Ana Sousa (2020.07919.BD). We also acknowledge the PhD grant awarded to Juliana Andrade (CsF n°246713/2012‐7). The NMR spectrometer Bruker Avance III 400 is part of the National NMR Network (RNRMN) and was purchased within the framework of the National Program for Scientific Re‐equipment, contract REDE/1517/RMN/2005 with funds from POCI 2010 (European Regional Development Fund‐ERDF) and FCT. This work was also developed under the project NORTE‐01‐0145‐FEDER‐000055, by the Northern Portugal Regional Operational Program (NORTE 2020), through the ERDF and the Competitiveness Factors Operational Program (COMPETE) and by National funds, through FCT (ref. POCI‐01‐0145‐FEDER‐007038)."